Page last updated: 2024-08-24

2,2'-dithiodiethanesulfonic acid and Kidney Diseases

2,2'-dithiodiethanesulfonic acid has been researched along with Kidney Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayala, PY; Chen, S; Chen, X; Hausheer, FH; Huang, Q; Jair, KW; Kochat, H; Parker, AR; Petluru, PN; Shanmugarajah, D1
Boven, E; Giaccone, G; Ruijter, R; van der Vijgh, WJ; van Groeningen, CJ; Verschraagen, M; Westerman, M; Zegers, I1
Brock, N; Stekar, J1
Cao, S; Haridas, K; Hausheer, FH; Kanter, P; Martinez, N; Murali, D; Petluru, P; Reddy, D; Rustum, YM; Saxe, JD; Seetharamulu, P; Yao, S; Zhao, M; Zukowski, A1

Reviews

1 review(s) available for 2,2'-dithiodiethanesulfonic acid and Kidney Diseases

ArticleYear
Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents.
    Seminars in oncology, 1998, Volume: 25, Issue:5

    Topics: Amifostine; Animals; Antineoplastic Agents; Cisplatin; Drug Interactions; Humans; Kidney Diseases; Mesna; Platinum Compounds; Protective Agents; Sulfhydryl Compounds

1998

Trials

1 trial(s) available for 2,2'-dithiodiethanesulfonic acid and Kidney Diseases

ArticleYear
Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule.
    British journal of cancer, 2005, May-09, Volume: 92, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dehydration; Female; Humans; Kidney Diseases; Male; Mesna; Middle Aged; Neoplasms

2005

Other Studies

2 other study(ies) available for 2,2'-dithiodiethanesulfonic acid and Kidney Diseases

ArticleYear
Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N.
    Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:2

    Topics: Allosteric Regulation; Biocatalysis; CD13 Antigens; Cisplatin; Cysteine; Dipeptides; Glutathione; Glycine; Humans; Kidney Diseases; Kinetics; Mesna; Models, Biological; Protective Agents; Recombinant Proteins

2011
[Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
    Arzneimittel-Forschung, 1982, Volume: 32, Issue:5

    Topics: Animals; Cyclophosphamide; Ifosfamide; Kidney Diseases; Mercaptoethanol; Mesna; Oxidation-Reduction; Rats; Rats, Inbred Strains

1982